Great West Life Assurance CO Corcept Therapeutics Inc Transaction History

Great West Life Assurance CO

  • $58 Billion
  • Q4 2024

A detailed history of Great West Life Assurance CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 104,734 shares of CORT stock, worth $6.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
104,734
Previous 88,896 17.82%
Holding current value
$6.52 Million
Previous $4.12 Million 28.09%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$44.66 - $60.85 $707,325 - $963,742
15,838 Added 17.82%
104,734 $5.27 Million
Q3 2024

Nov 13, 2024
SELL
$29.51 - $46.26 $94,372 - $147,939
-3,198 Reduced 3.47%
88,896 $4.12 Million
Q2 2024

Aug 12, 2024
BUY
$22.21 - $34.48 $291,106 - $451,929
13,107 Added 16.59%
92,094 $2.99 Million
Q1 2024

May 13, 2024
SELL
$21.1 - $27.46 $273,920 - $356,485
-12,982 Reduced 14.12%
78,987 $1.99 Million
Q4 2023

Feb 13, 2024
SELL
$24.82 - $32.88 $29,262 - $38,765
-1,179 Reduced 1.27%
91,969 $2.98 Million
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $54,661 - $84,094
2,488 Added 2.74%
93,148 $2.54 Million
Q2 2023

Aug 10, 2023
SELL
$21.44 - $25.15 $220,424 - $258,567
-10,281 Reduced 10.19%
90,660 $2.02 Million
Q1 2023

May 12, 2023
SELL
$19.2 - $24.47 $465,907 - $593,789
-24,266 Reduced 19.38%
100,941 $2.18 Million
Q4 2022

Feb 10, 2023
BUY
$19.95 - $29.96 $369,553 - $554,979
18,524 Added 17.36%
125,207 $2.55 Million
Q3 2022

Nov 01, 2022
BUY
$24.7 - $29.12 $295,708 - $348,624
11,972 Added 12.64%
106,683 $2.73 Million
Q2 2022

Aug 12, 2022
BUY
$17.33 - $25.3 $1.64 Million - $2.4 Million
94,711 New
94,711 $2.25 Million
Q2 2022

Aug 09, 2022
SELL
$17.33 - $25.3 $1.43 Million - $2.08 Million
-82,268 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$16.53 - $25.21 $1,950 - $2,974
118 Added 0.14%
82,268 $1.9 Million
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $173,992 - $237,484
-10,175 Reduced 11.02%
82,150 $1.63 Million
Q3 2021

Nov 15, 2021
BUY
$19.68 - $22.53 $37,313 - $42,716
1,896 Added 2.1%
92,325 $1.83 Million
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $280,447 - $364,855
-11,939 Reduced 11.66%
90,429 $2.15 Million
Q4 2020

Feb 16, 2021
SELL
$16.78 - $27.3 $218,358 - $355,254
-13,013 Reduced 11.28%
102,368 $2.68 Million
Q3 2020

Nov 17, 2020
SELL
$12.46 - $19.98 $867,228 - $1.39 Million
-69,601 Reduced 37.63%
115,381 $2.01 Million
Q3 2020

Nov 13, 2020
BUY
$12.46 - $19.98 $712,936 - $1.14 Million
57,218 Added 44.78%
184,982 $3.22 Million
Q2 2020

Aug 17, 2020
SELL
$11.0 - $18.26 $96,239 - $159,756
-8,749 Reduced 6.41%
127,764 $2.15 Million
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $87,229 - $121,137
8,628 Added 6.75%
136,513 $1.62 Million
Q4 2019

Feb 11, 2020
BUY
$12.06 - $16.96 $1.54 Million - $2.17 Million
127,885 New
127,885 $1.55 Million
Q3 2019

Oct 25, 2019
SELL
$10.41 - $14.66 $1.45 Million - $2.05 Million
-139,501 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$11.29 - $17.19 $139,262 - $212,038
12,335 Added 9.7%
139,501 $1.72 Million
Q3 2018

Nov 13, 2018
BUY
$12.27 - $15.65 $54,147 - $69,063
4,413 Added 3.6%
127,166 $1.78 Million
Q1 2018

May 10, 2018
BUY
$14.59 - $25.5 $68,558 - $119,824
4,699 Added 3.98%
122,753 $2.02 Million
Q4 2017

Feb 09, 2018
BUY
$15.77 - $20.72 $1.74 Million - $2.29 Million
110,442 Added 1450.89%
118,054 $2.13 Million
Q3 2017

Nov 09, 2017
BUY
$12.3 - $19.3 $93,627 - $146,911
7,612
7,612 $144,000

Others Institutions Holding CORT

# of Institutions
414
Shares Held
84.9M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.67B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email